Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis

Nutrients. 2023 Feb 1;15(3):749. doi: 10.3390/nu15030749.

Abstract

Eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6), two omega-3 poly-unsaturated fatty acids (PUFAs), are the main components in oil derived from fish and other marine organisms. EPA and DHA are commercially available as dietary supplements and are considered to be very safe and contribute to guaranteeing human health. Studies report that PUFAs have a role in contrasting neurodegenerative processes related to amyloidogenic proteins, such as β-amyloid for AD, α-synuclein in PD, and transthyretin (TTR) in TTR amyloidosis. In this context, we investigated if EPA and DHA can interact directly with TTR, binding inside the thyroxin-binding pockets (T4BP) that contribute to the tetramer stabilization. The data obtained showed that EPA and DHA can contribute to stabilizing the TTR tetramer through interactions with T4BP.

Keywords: DHA; EPA; TTR; amyloidosis; diet; fatty acids; fish oil; neuroprotection; omega 3; supplements.

MeSH terms

  • Amyloidosis*
  • Animals
  • Dietary Supplements
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid
  • Fatty Acids, Omega-3*
  • Humans

Substances

  • Fatty Acids, Omega-3
  • Eicosapentaenoic Acid
  • Docosahexaenoic Acids